ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Down 70.7% in December

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 15,700 shares, a decrease of 70.7% from the November 30th total of 53,500 shares. Based on an average trading volume of 279,600 shares, the days-to-cover ratio is presently 0.1 days.

ProtoKinetix Stock Performance

Shares of PKTX stock traded up $0.00 during trading on Friday, reaching $0.01. 21,272 shares of the company’s stock traded hands, compared to its average volume of 121,706. ProtoKinetix has a 1 year low of $0.01 and a 1 year high of $0.02. The firm’s 50-day moving average is $0.01 and its 200 day moving average is $0.01.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.